Anlon Healthcare Delivers Over 102% Profit Growth in H1 FY26 & 259% in Q2FY26 Driven by Robust R&D and Expanding API Portfolio

Rajkot, 13th November 2025 – Anlon Healthcare Limited, one of India’s leading manufacturers of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs), announced its unaudited [Read More…]

Anlon Healthcare Delivers Over 102% Profit Growth in H1 FY26 & 259% in Q2FY26 Driven by Robust R&D and Expanding API Portfolio – India Bulletin Live

Rajkot, 13th November 2025 – Anlon Healthcare Limited, one of India’s leading manufacturers of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs), announced its unaudited [Read More…]